KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Current Assets: 2018-2025

Historic Current Assets for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $333.0 million.

  • Twist Bioscience's Current Assets fell 3.98% to $333.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $333.0 million, marking a year-over-year decrease of 3.98%. This contributed to the annual value of $333.0 million for FY2025, which is 3.98% down from last year.
  • Latest data reveals that Twist Bioscience reported Current Assets of $333.0 million as of FY2025, which was down 3.98% from $346.8 million recorded in FY2024.
  • Over the past 5 years, Twist Bioscience's Current Assets peaked at $596.5 million during FY2022, and registered a low of $333.0 million during FY2025.
  • Moreover, its 3-year median value for Current Assets was $346.8 million (2024), whereas its average is $368.0 million.
  • Per our database at Business Quant, Twist Bioscience's Current Assets skyrocketed by 63.20% in 2021 and then decreased by 28.87% in 2023.
  • Twist Bioscience's Current Assets (Yearly) stood at $546.5 million in 2021, then increased by 9.15% to $596.5 million in 2022, then dropped by 28.87% to $424.3 million in 2023, then declined by 18.26% to $346.8 million in 2024, then decreased by 3.98% to $333.0 million in 2025.